A detailed history of Fora Capital, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Fora Capital, LLC holds 16,752 shares of NBIX stock, worth $2.1 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
16,752
Holding current value
$2.1 Million
% of portfolio
0.24%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$114.58 - $153.15 $1.92 Million - $2.57 Million
16,752 New
16,752 $1.93 Million
Q2 2023

Aug 11, 2023

SELL
$89.53 - $104.87 $659,567 - $772,577
-7,367 Reduced 76.22%
2,298 $216,000
Q1 2023

May 12, 2023

BUY
$94.11 - $123.02 $909,573 - $1.19 Million
9,665 New
9,665 $978,000
Q3 2022

Nov 14, 2022

BUY
$92.03 - $107.81 $761,272 - $891,804
8,272 New
8,272 $879,000
Q3 2021

Nov 15, 2021

SELL
$86.18 - $99.03 $246,733 - $283,522
-2,863 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$89.43 - $102.27 $23,072 - $26,385
-258 Reduced 8.27%
2,863 $279 Million
Q1 2021

May 17, 2021

BUY
$87.57 - $119.4 $273,305 - $372,647
3,121 New
3,121 $304 Million
Q4 2020

Feb 12, 2021

SELL
$86.91 - $108.33 $191,549 - $238,759
-2,204 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$96.16 - $135.15 $321,270 - $451,536
-3,341 Reduced 60.25%
2,204 $212 Million
Q2 2020

Aug 14, 2020

BUY
$85.09 - $130.36 $471,824 - $722,846
5,545 New
5,545 $676 Million
Q1 2020

May 15, 2020

SELL
$75.11 - $113.76 $621,985 - $942,046
-8,281 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$86.8 - $118.57 $718,790 - $981,878
8,281 New
8,281 $890,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Fora Capital, LLC Portfolio

Follow Fora Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fora Capital, LLC with notifications on news.